Tango Therapeutics, Inc. (TNGX)
12.20
-0.15
(-1.21%)
USD |
NASDAQ |
Feb 20, 16:00
12.20
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics SG&A Expense (Quarterly) : 8.924M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| AbbVie, Inc. | 3.895B |
| Teleflex, Inc. | 281.76M |
| Recursion Pharmaceuticals, Inc. | 41.63M |
| Amicus Therapeutics, Inc. | 90.04M |
| EyePoint Plc | 14.52M |